Why you shouldn’t buy the kenya-brand products of a company that manufactures “fake” vaccines
The world’s biggest dairy producer is reportedly trying to get out of a legal battle with the manufacturer of a vaccine made with a product labeled as “fake.”
Kenya-based Borden Brands announced last week that it was dropping its lawsuit against the manufacturer, and is instead seeking to settle the matter with the company in arbitration.
The move is part of a broader push by Borden to get more transparency about its products and to improve its transparency reporting.
The company is also pursuing an arbitration case against the maker of another vaccine, Merck.
The vaccine maker is now seeking to get the government to declare the vaccines “legally defective,” saying the company’s business model requires it to pay to settle such disputes.
In a statement, Borden spokesman Jeff Faucher wrote: “The court-ordered declaration of non-compliance would have no impact on the company and would have little impact on Borden’s business.
The FDA’s declaration would only be an advisory decision, and any subsequent ruling on the matter would be determined by the court.”
In a separate move, the maker is also seeking to resolve a separate dispute with the government over whether it must report sales of its vaccines to the FDA.
Borden said in a filing with the U.S. District Court for the District of Columbia that the FDA and the Justice Department have filed a lawsuit to compel the company to disclose its sales data.
Bond says he hopes to win more settlements and that the company will soon disclose how many people have received the vaccines.